Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Sexually Transmitted Diseases

  Free Subscription


Articles published in Br J Cancer

Retrieve available abstracts of 19 articles:
HTML format



Single Articles


    September 2025
  1. DE OLIVEIRA THA, Anderson LA, Craig SG, Coleman HG, et al
    Methodological considerations in assessing HPV prevalence in Barrett's oesophagus progression.
    Br J Cancer. 2025 Sep 19. doi: 10.1038/s41416-025-03168.
    PubMed    


  2. GORI S, Venturelli F, Carozzi F, Giorgi Rossi P, et al
    Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology.
    Br J Cancer. 2025 Sep 11. doi: 10.1038/s41416-025-03161.
    PubMed     Abstract available


  3. MATHEWS CS, Sargent A, Cuschieri K, Rebolj M, et al
    HPValidate-human papillomavirus testing with DNA and mRNA assays on self-collected samples in cervical screening: comparison of test characteristics on three self-sampling devices.
    Br J Cancer. 2025;133:665-673.
    PubMed     Abstract available


    July 2025
  4. SIMBA H, McCormack V, Bilaba J, Mmbaga BT, et al
    Non-melanoma skin cancer and HPV in persons with albinism: a call for research investment.
    Br J Cancer. 2025 Jul 4. doi: 10.1038/s41416-025-03107.
    PubMed     Abstract available


    June 2025
  5. DE OLIVEIRA THA, Anderson LA, Craig SG, Coleman HG, et al
    Infectious agents and progression from Barrett's oesophagus to oesophageal adenocarcinoma: a nested case-control study.
    Br J Cancer. 2025;132:1050-1055.
    PubMed     Abstract available


    April 2025
  6. SU H, Jin X, Kong L, You Y, et al
    The triage role of cytological DNA methylation in women with non-16/18, specifically genotyping high-risk HPV infection.
    Br J Cancer. 2025 Apr 10. doi: 10.1038/s41416-025-03005.
    PubMed     Abstract available


    May 2024
  7. OLIVA M, Heirali A, Watson G, Rooney AM, et al
    Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study.
    Br J Cancer. 2024 May 7. doi: 10.1038/s41416-024-02701.
    PubMed     Abstract available


  8. REBOLJ M, Brentnall AR, Cuschieri K
    Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening.
    Br J Cancer. 2024;130:1733-1743.
    PubMed     Abstract available


    April 2024
  9. TABATABAEIAN H, Bai Y, Huang R, Chaurasia A, et al
    Navigating therapeutic strategies: HPV classification in head and neck cancer.
    Br J Cancer. 2024 Apr 20. doi: 10.1038/s41416-024-02655.
    PubMed     Abstract available


    January 2024
  10. WANG Y, He M, He T, Ouyang X, et al
    Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers.
    Br J Cancer. 2024 Jan 22. doi: 10.1038/s41416-023-02555.
    PubMed     Abstract available


  11. STOGBAUER F, Beck S, Ourailidis I, Hess J, et al
    Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.
    Br J Cancer. 2024 Jan 8. doi: 10.1038/s41416-023-02521.
    PubMed    


    November 2023
  12. DOWNHAM L, Jaafar I, Rol ML, Nyawira Nyaga V, et al
    Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.
    Br J Cancer. 2023 Nov 16. doi: 10.1038/s41416-023-02490.
    PubMed     Abstract available


    October 2023
  13. LO CIGNO I, Calati F, Girone C, Borgogna C, et al
    SIRT1 is an actionable target to restore p53 function in HPV-associated cancer therapy.
    Br J Cancer. 2023 Oct 14. doi: 10.1038/s41416-023-02465.
    PubMed     Abstract available


    August 2023
  14. CUSCHIERI K, Palmer T, Graham C, Cameron R, et al
    The changing nature of HPV associated with high grade cervical lesions in vaccinated populations, a retrospective study of over 1700 cases in Scotland.
    Br J Cancer. 2023 Aug 10. doi: 10.1038/s41416-023-02386.
    PubMed     Abstract available


    April 2023
  15. VERHOEF L, Bleeker MCG, Polman N, Steenbergen RDM, et al
    Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.
    Br J Cancer. 2023 Apr 26:1-8. doi: 10.1038/s41416-023-02277.
    PubMed     Abstract available


  16. KAMAL M, Lameiras S, Deloger M, Morel A, et al
    Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
    Br J Cancer. 2023 Apr 13. doi: 10.1038/s41416-023-02261.
    PubMed    


  17. STOGBAUER F, Beck S, Ourailidis I, Hess J, et al
    Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.
    Br J Cancer. 2023 Apr 12. doi: 10.1038/s41416-023-02240.
    PubMed     Abstract available


    March 2023
  18. MITTELSTADT S, Kelemen O, Admard J, Gschwind A, et al
    Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse.
    Br J Cancer. 2023 Mar 27. doi: 10.1038/s41416-023-02233.
    PubMed     Abstract available


  19. GILHAM C, Sargent A, Crosbie EJ, Peto J, et al
    Long-term risks of invasive cervical cancer following HPV infection: follow-up of two screening cohorts in Manchester.
    Br J Cancer. 2023 Mar 23. doi: 10.1038/s41416-023-02227.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.